For citations:
Avxentyev N.A., Khokhlova S.V., Frolov M.Yu., Makarov A.S. Estimating long-term overall survival with olaparib as maintenance therapy in patients with newly diagnosed advanced ovarian cancer with BRCA mutations. Tumors of female reproductive system. 2021;17(3):97-105. (In Russ.) https://doi.org/10.17650/1994-4098-2021-17-3-97-105
Email this article 